• Wed, March 27, 2024

Ross Osborn Maintained (SMTI) at Buy with Decreased Target to $44 on, Mar 27th, 2024

Ross Osborn of Cantor Fitzgerald, Maintained "Sanara MedTech Inc." (SMTI) at Buy with Decreased Target from $49 to $44 on, Mar 27th, 2024.

Ross, nor any peers, have made any analyst calls on SMTI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍